败血症或败血性休克患者的宏类疗法:系统性审查和元分析
1Division of Pulmonology and Allergy, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.
Journal of clinical medicine
|September 13, 2025
概括
根据随机对照试验,麦克罗利德治疗没有显著降低败血症或败血性休克患者的死亡率. 需要进一步的研究来确认宏化物.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 败血症和败血性休克是危及生命的疾病,死亡率高.
- 新出现的证据表明,宏类可能会提供超越抗生素作用的益处,可能是通过免疫调节.
- 化物在败血症管理中的作用需要进一步研究.
研究的目的:
- 评估宏类药物治疗治疗败血症或败血性休克患者的有效性.
- 为了确定类物质是否影响整体死亡率,重症监护室 (ICU) 停留时间 (LOS) 和医院LOS.
- 根据类型和败血症的主要原因分析结果.
主要方法:
- 在电子生物医学数据库中进行了系统的文献搜索.
- 包括的研究比较了类药物治疗与非类药物治疗的败血症患者.
- 主要结局是整体死亡率;次要结局包括ICU和医院LOS. 使用随机效应模型计算了聚合风险比率和平均差异.
主要成果:
- 分析了四项随机对照试验 (RCT) 和七项观察性研究.
- 风险试验表明,宏类和对照组之间的总死亡率没有显著差异 (RR 1.08,95% CI 0.92-1.27).
- 观察性研究表明,宏类药物治疗显著降低了死亡率 (RR 0.79,95% CI 0.65-0.95),但在RCT中的子组分析没有发现死亡率或LOS的显著差异.
结论:
- 目前来自RCT的证据表明,辅助的宏类药物治疗不会显著改善败血症或败血性休克的生存率.
- 显示受益的观测数据需要谨慎解释,因为可能存在偏差.
- 需要进行更大规模,高质量的随机试验,以确定宏类药物在败血症管理中的作用.
相关概念视频
Pneumonia IV: Management
756
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756
Acute Pyelonephritis II: Diagnostic Studies and Management
321
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
321
Endocarditis III: Medical Management
213
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
213
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
329
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
329


